1.51
price up icon1.34%   0.02
after-market Handel nachbörslich: 1.51
loading

Finanzdaten der Cocrystal Pharma Inc-Aktie (COCP)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
10.89%
4.158
4.666 4.443 4.339 5.111
Depreciation and Amortization
12.50%
0.035
0.04 0.053 0.047 0.049
Operating Income/Loss
10.89%
-4.158
-4.666 -4.443 -4.339 -5.111
Nonoperating Income/Loss
0.00%
0.202
0.202 0.278 - -0.078
Income/Loss From Continuing Operations Before Tax
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Income/Loss From Continuing Operations After Tax
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Net Income/Loss
11.38%
-3.956
-4.464 -4.165 -4.166 -5.189
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
5,255%
10.17
0.19 10.15 10.06 8.143
Diluted Average Shares
5,255%
10.17
0.19 10.15 10.06 -0.956
Basic Earnings Per Share
11.36%
-0.39
-0.44 -0.41 -0.41 -0.64
Diluted Earnings Per Share
11.36%
-0.39
-0.44 -0.41 -0.41 -0.62
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):